Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.068 CHF | +2.41% | -2.64% | +44.35% |
10:03am | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
08/05 | Addex to Present at BioEURquity Europe 2024 | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.35% | 95.22L | |
+55.70% | 5.93TCr | |
+42.83% | 4.02TCr | |
-5.39% | 3.99TCr | |
-5.56% | 2.86TCr | |
+16.46% | 2.73TCr | |
-20.56% | 1.92TCr | |
+33.03% | 1.26TCr | |
+2.72% | 1.25TCr | |
+25.85% | 1.23TCr |
- Stock Market
- Equities
- ADXN Stock
- News Addex Therapeutics Ltd
- Addex Therapeutics Expects Data From Three Ongoing Clinical Programs In 2022